MADISON, Conn., April 21 /PRNewswire/ -- Results from the initial clinical trial of the ClariVein(R) catheter, used in a new minimally invasive treatment for varicose veins, have been announced. The device combines mechanical and chemical modalities to accomplish vein treatment in an in-office setting.
Thirty patients with an average age of 55 were part of this first-in-man trial. Most patients had symptomatic varicose veins, with some having more advanced vein disease such as swelling and skin changes. Mean vein diameter was 8.1 mm. Treatment for each vein averaged 5 minutes and overall procedure time was 14 minutes.
“The main advantage of this new technique in comparison to older endovenous therapies,” Dr. Elias said, “is that it does not require tumescence anesthesia infusion, saving significant time and decreasing patient discomfort. In addition, a generator is not required, and therefore capital and maintenance cost is reduced. This in-office procedure takes about 15 minutes to perform and patients resume normal activity that day, including exercise. All patients would recommend the procedure to others.”
The ClariVein(R) catheter is a product of Vascular Insights LLC (http://vascularinsights.com) of Madison, CT. The company engages in the design, development, manufacture, and marketing of medical devices for the minimally invasive treatment of peripheral vascular disease.
Photos of the device can be downloaded from http://vascularinsights.com/devicepix4-complete.htm.
CONTACT: Bill Kelly, HarveyMalis Communications LLC, +1-203-375-2696,
bill@harveymalis.com
Web site: http://vascularinsights.com/
